GlaxoSmithKline to Pay $3 Billion Fine

(1:34)

GlaxoSmithKline to invest £100m

(2:17)

GlaxoSmithKline to stop paying doctors by 2016

(1:13)

Glaxo Gets Ready to Split in Two

(6:39)

GlaxoSmithKline CEO: Pursuing Drug Approvals | Mad Money | CNBC

(9:47)

GlaxoSmithKline to raise stake in Indian unit

(5:10)

Drugmaker GlaxoSmithKline 'guilty of fraud'

(2:5)

Sanofi, Glaxosmithkline to launch COVID-19 vaccine clinical trial

(38)

GlaxoSmithKline bribery probe widens - economy

(36)

GlaxoSmithKline involved in a corruption scandal in China

(1:29)

Kenyan Medical researchers welcome the move by GlaxoSmithKline to have RTS's Vaccine approved

(2:40)

BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline

(55:47)

The David Rubenstein Show: GSK CEO Emma Walmsley

(24:6)

GSK HUL Deal

(30:8)

GlaxoSmithKline STARLIMS Implementation Case Study

(46:47)

GlaxoSmithKline CEO: I Don't Define Work By My Gender

(3:)

Glaxo CEO: Game-Changing HIV Drugs Are on the Way

(4:12)

GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses

(7:11)

GSK Exits Nigeria: Glaxosmithkline To End Operations After 51 Years | Nigeria Tonight | 04-08-23

(6:48)

GlaxoSmithKline on Vaccines

(4:54)

GSK – Our story

(3:57)

GlaxoSmithKline announces $300 million equity investment in 23andMe

(3:28)

Skill Sets Live: GlaxoSmithKline

(5:22)

GlaxoSmithKline issues apology for bribery case

(1:39)

GlaxoSmithKline Receives $54.4 Million Fine In UK For Pay-For-Delay Deal

(2:37)

Letting Science Drive Technology at GlaxoSmithKline

(32:15)